| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPHEART.00061.2006 |
| P698 | PubMed publication ID | 16766648 |
| P2093 | author name string | Jewell A Jessup | |
| Mark C Chappell | |||
| Carlos M Ferrario | |||
| Patricia E Gallagher | |||
| K Bridget Brosnihan | |||
| E Ann Tallant | |||
| David B Averill | |||
| P433 | issue | 5 | |
| P921 | main subject | hypertension | Q95566669 |
| P304 | page(s) | H2166-72 | |
| P577 | publication date | 2006-06-09 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats | |
| P478 | volume | 291 |
| Q37262837 | ACE2 alterations in kidney disease |
| Q34866649 | ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury |
| Q91712173 | Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts |
| Q55465043 | Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7). |
| Q91703665 | Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System |
| Q37155907 | Angiotensin-converting enzyme 2 in the brain: properties and future directions |
| Q35550937 | Angiotensin-converting enzyme 2: the first decade |
| Q94553679 | Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus |
| Q34423315 | Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. |
| Q47685507 | Blunting of cardioprotective actions of estrogen in female rodent heart linked to altered expression of cardiac tissue chymase and ACE2. |
| Q37281123 | Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. |
| Q98209622 | Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic" |
| Q37070124 | Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction |
| Q33674294 | Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat. |
| Q30415031 | Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension. |
| Q98184301 | Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 |
| Q91946856 | Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 |
| Q51747739 | Integrative Physiological Aspects of Brain RAS in Hypertension. |
| Q98774280 | Is Sex a Determinant of COVID-19 Infection? Truth or Myth? |
| Q43050349 | Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients |
| Q37147841 | New angiotensins |
| Q37660786 | New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism |
| Q37262234 | Pharmacologic modulation of ACE2 expression |
| Q36853840 | Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats |
| Q37142740 | Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism |
| Q37038738 | Regulation of ACE2 in cardiac myocytes and fibroblasts |
| Q37233102 | Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats |
| Q27026798 | Role of estrogen in diastolic dysfunction |
| Q36013124 | Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy |
| Q36807861 | Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats |
| Q90595084 | Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade |
| Q24633556 | The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function |
| Q36804138 | The emerging role of ACE2 in physiology and disease |
| Q35284694 | The functional role of PI3K in maintenance of blood pressure and baroreflex suppression in (mRen2)27 and mRen2.Lewis rat. |
| Q98153297 | The kidney, COVID-19, and the chemokine network: an intriguing trio |
| Q93237239 | The pivotal link between ACE2 deficiency and SARS-CoV-2 infection |
| Q36974726 | Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice. |
| Q54538860 | Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy. |
Search more.